VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
REGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
REGNRegeneron Pharmaceuticals, Inc.
$945.53$97.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksREGNQuarterly Cash Flow

Regeneron Pharmaceuticals, Inc. (REGN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Regeneron Pharmaceuticals, Inc. (REGN) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

REGN Cash Flow Statement

Quarterly statement

REGN Cash Flow Statement

Regeneron Pharmaceuticals, Inc. (REGN) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations1.78B574.5M1.08B1.17B1.62B1.14B1.05B1.26B1.29B354M1.51B1.09B1.11B1.02B1.37B1.72B628.9M564.4M2.1B2.37B
Operating CF Margin %34.86%13.39%29.92%30.14%43.12%31.14%34.51%33.33%34.7%9.98%48.09%31.73%33.14%32.37%43.25%50.37%21.42%19.75%70.88%47.91%
Operating CF Growth %10.17%-49.8%3.23%-7.29%25.36%223.28%-30.9%15.89%15.88%-65.38%10.6%-36.64%77.18%81.15%-34.93%-27.51%-81.58%-9.94%214.39%92.73%
Net Income1.95B1.3B727.2M844.6M1.46B1.39B808.7M917.7M1.34B1.43B722M1.16B1.01B968.4M817.8M1.2B1.32B852.1M973.5M2.23B
Depreciation & Amortization121M123.7M123.2M145M136.7M135.1M126.9M126.4M121.7M120.7M114.1M113M105.4M103.1M99.5M100.1M92.6M74.4M74.3M74.5M
Stock-Based Compensation255.8M243M257.4M249.3M237M251.7M255.7M304.4M225.1M223.2M230.1M240.4M203.9M202M238.7M232M166.3M159.8M166.9M188.4M
Deferred Taxes-182.3M-194.4M-96M-232.5M-278.6M-135.2M-139.1M-280.2M-168.6M-118.1M-190.4M-286.3M-125.7M-209.3M-216.5M-279.7M-85.7M-156M-225M-205.9M
Other Non-Cash Items30.8M-733.6M144.5M158.4M-561.4M-270.9M-136.7M280.9M-695.6M-395.6M196.2M-75.6M115.2M39.5M187.2M88.4M-192.8M415.4M288.8M441.9M
Working Capital Changes-390.6M-161.1M-77.4M5.9M625M-227.9M129.6M-86.4M468M-908.5M440.5M-61.4M-192.3M-81.3M240.9M382M-667.2M-781.3M823.2M-355.4M
Change in Receivables-1.01B-838.5M1.2M-51.2M-80.3M-28.2M657.8M-117.8M-388.9M-494.1M446.8M-82.7M-463.5M-2.7M210.1M219.6M-386.9M-322.4M1.2B-584.5M
Change in Inventory112.3M-28.2M26.6M2.1M-82.6M-42.5M-152.3M-117.7M-164.4M-181.8M-155.8M-47.3M-77.2M-100.4M-46.8M-144.3M-223.5M-240.1M-88.6M-163.7M
Change in Payables784.5M492.7M107.7M-24.7M759.2M216.4M-214.1M225.6M194.4M204.6M110.5M25.6M303.1M39.7M119M347.6M-160.3M-75.3M-250.4M365.7M
Cash from Investing-288.1M-92.7M-428.9M220.3M-402.9M-1.09B647.5M350.6M-574.4M-557.2M-1.69B-66.2M-496.3M-2.39B-235.7M-1.86B192.3M-413.9M-1.71B-2.01B
Capital Expenditures-300.2M-240.2M-230.6M-290.7M-244.7M-406.8M-271.5M-267M-183.6M-210.9M-161.8M-313.5M-176M-113M-178.2M-152.2M-142.5M-153.6M-141.8M-154.9M
CapEx % of Revenue5.87%5.6%6.4%7.48%6.52%11.07%8.96%7.05%4.93%5.95%5.14%9.13%5.23%3.58%5.64%4.46%4.85%5.38%4.78%3.13%
Acquisitions000-300K-3M00-11.5M-20.1M15.1M0-3.8M199.9M133.9M100.9M1.62B-1.26B-230.3M1.56B0
Investments--------------------
Other Investing-56.3M-51M-48.9M00000-38.2M000-274.9M-154.8M-201.8M-1.72B334.8M0-1.56B0
Cash from Financing-290.2M-2.34B-802.2M-780.1M-717.9M-1.13B-1.09B-1.14B-634M-478.1M47.1M-446.1M-407.3M-614.2M-322.5M-247.6M-725M-101.1M64.7M-906.6M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)-98.8M-1.12B-631.2M-168.2M-623.7M-1.03B-985.1M-882.1M-480.4M-166.3M390.8M12M-277.9M-598.1M-225.5M-58.5M-616.1M-52.2M163.5M-324.2M
Dividends Paid-95.7M-96.8M-97.8M-92.7M-91.2M-92.6M-93.8M0000000000000
Share Repurchases-399.7M-1.17B-794.3M-671.7M-664M-1.06B-1.05B-973M-735.1M-603.9M-291.3M-747.1M-675.9M-704.9M-807.7M-620.2M-1.04B-407.9M-456.9M-1.45B
Other Financing-95.7M-1.13B-73.2M-519.2M-3M-5.6M-10.3M-253.4M-153.6M-311.8M-343.7M-458.1M-129.4M-16.1M-97M-189.1M-108.9M-48.9M-98.8M-582.4M
Net Change in Cash1.21B-1.86B-153.1M610.6M497.5M-1.08B604M477.2M83.6M-681.6M-128M577.6M210.5M-1.98B809.4M-385.4M96.2M49.4M461.1M-546.8M
Free Cash Flow1.48B334.3M848.3M922M1.42B967.6M773.6M995.8M1.11B143.1M1.35B776.2M938.3M909.4M1.19B1.57B486.4M410.8M1.96B2.22B
FCF Margin %28.99%7.79%23.53%23.74%37.75%26.32%25.54%26.28%29.77%4.03%42.95%22.6%27.9%28.8%37.61%45.91%16.57%14.38%66.1%44.78%
FCF Growth %4.65%-65.45%9.66%-7.41%27.96%576.17%-42.73%28.29%18.04%-84.26%13.56%-50.49%92.91%121.37%-39.31%-29.31%-85.17%-14.09%254.28%107.33%
FCF per Share14.053.137.888.5813.228.916.968.759.531.2411.746.828.277.9810.4313.754.313.6017.3319.59
FCF Conversion (FCF/Net Income)0.92x0.44x1.48x1.39x1.11x0.82x1.29x1.38x0.96x0.25x2.09x0.94x1.11x1.06x1.67x1.44x0.48x0.66x2.16x1.06x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000